Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
193,394,759
-
Total 13F shares
-
25,962,454
-
Share change
-
+3,734,887
-
Total reported value
-
$86,372,263
-
Put/Call ratio
-
215%
-
Price per share
-
$3.33
-
Number of holders
-
87
-
Value change
-
+$11,913,177
-
Number of buys
-
44
-
Number of sells
-
27
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q1 2021
As of 31 Mar 2021,
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,962,454 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, VANGUARD GROUP INC, BlackRock Inc., Hudson Bay Capital Management LP, ADVISOR GROUP HOLDINGS, INC., MORGAN STANLEY, Point72 Asset Management, L.P., RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA INVESTMENTS, LP, and CITADEL ADVISORS LLC.
This page lists
89
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.